views
BANGALORE: GE Healthcare announced that the National Aeronautics and Space Administration (NASA) has selected GE Healthcare's Vivid q Cardiovascular Ultrasound system for delivery to the International Space Station (ISS) on its final space shuttle flight.
The Vivid q will be launched on the space shuttle Atlantis, scheduled to launch on July 8. NASA selected the Vivid q following a rigorous regimen of spaceflight hardware qualification and acceptance testing. The customised Vivid q will be used onboard ISS as part of NASA's human research program, specifically to help assess the impact of long duration microgravity space flight on astronauts.Al Lojewski, Vice President and General Manager of GE Healthcare's Cardiovascular Ultrasound Unit said, "We are excited that the Vivid q's exceptional imaging capabilities will also now support NASA's important research in space flight and the impact of space travel on the human physiology."
Comments
0 comment